Effects of dabigatran versus warfarin on 2-year cognitive outcomes in old patients with atrial fibrillation: results from the GIRAF randomized clinical trial.
Bruno CaramelliPai Ching YuFrancisco A M CardozoIuri R MagalhãesRaphael R SperaDaniel K AmadoMaria C Escalante-RojasDanielle M GualandroDaniela CalderaroCaio A M TavaresFlavio A Borges-JuniorAdriana F PastanaMariana G MatheusSonia M D BruckiAna Carolina O RodriguesRicardo NitriniPaulo CaramelliPublished in: BMC medicine (2022)
Cognitive Impairment Related to Atrial Fibrillation Prevention Trial (GIRAF), NCT01994265 .
Keyphrases
- double blind
- atrial fibrillation
- phase iii
- cognitive impairment
- clinical trial
- phase ii
- study protocol
- oral anticoagulants
- direct oral anticoagulants
- left atrial
- catheter ablation
- left atrial appendage
- heart failure
- percutaneous coronary intervention
- type diabetes
- coronary artery disease
- metabolic syndrome
- adipose tissue
- skeletal muscle
- weight loss